<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Representative reference ranges expected for serum androgens and steroid precursors in normal females and premature adrenarche (radioimmunoassay)*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Representative reference ranges expected for serum androgens and steroid precursors in normal females and premature adrenarche (radioimmunoassay)*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Representative reference ranges expected for serum androgens and steroid precursors in normal females and premature adrenarche (radioimmunoassay)*</div><div class="cntnt"><table cellspacing="0"><colgroup span="9" width="11%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">17-hydroxy-pregnenolone (ng/dL)</td> <td class="subtitle1">17-hydroxy-progesterone (ng/dL)<sup>¶</sup></td> <td class="subtitle1">11-deoxy-cortisol (ng/dL)</td> <td class="subtitle1">Cortisol (microgram/dL)</td> <td class="subtitle1">DHEAS (microgram/dL)</td> <td class="subtitle1">DHEA (ng/dL)</td> <td class="subtitle1">Androstenedione (ng/dL)</td> <td class="subtitle1">Testosterone (ng/dL)</td> </tr> <tr> <td class="subtitle2_left" colspan="9">Baseline (8:00 AM)</td> </tr> <tr> <td class="indent1">Children, 1 to 5 years old</td> <td>10-105</td> <td>5-115</td> <td>20-160</td> <td>3-20</td> <td>5-35</td> <td>20-130</td> <td>10-50</td> <td>&lt;20</td> </tr> <tr> <td class="indent1">Children, 6 to 10 years old</td> <td>10-200</td> <td>5-115</td> <td>20-160</td> <td>3-20</td> <td>10-115</td> <td>20-345</td> <td>10-75</td> <td>&lt;20</td> </tr> <tr> <td class="indent1"><em>Premature adrenarche</em></td> <td><em>20-350</em></td> <td><em>5-200</em></td> <td><em>20-160</em></td> <td><em>3-20</em></td> <td><em>40-130</em></td> <td><em>50-600</em></td> <td><em>20-75</em></td> <td><em>10-35</em></td> </tr> <tr> <td class="indent1">Early pubertal girls</td> <td>35-350</td> <td>15-200</td> <td>20-160</td> <td>3-20</td> <td>35-130</td> <td>40-600</td> <td>40-175</td> <td>10-35</td> </tr> <tr> <td class="indent1">Adult females, follicular phase<sup>Δ</sup></td> <td>55-360</td> <td>15-200</td> <td>20-160</td> <td>3-20</td> <td>75-255</td> <td>100-850</td> <td>60-200</td> <td>20-60</td> </tr> <tr> <td class="subtitle2_left" colspan="9">After ACTH<sub>1-24</sub> (cosyntropin); values are measured 30 to 60 minutes after ≥10 microgram/m<sup>2</sup> IV</td> </tr> <tr> <td class="indent1">Children, 1 to 5 years old</td> <td>45-350</td> <td>50-335</td> <td>95-300</td> <td>17-45</td> <td>5-35</td> <td>25-100</td> <td>15-70</td> <td>&lt;20</td> </tr> <tr> <td class="indent1">Children, 6 to 10 years old</td> <td>60-650</td> <td>85-335</td> <td>95-300</td> <td>17-45</td> <td>10-115</td> <td>70-320</td> <td>25-100</td> <td>&lt;20</td> </tr> <tr> <td class="indent1"><em>Premature adrenarche</em></td> <td><em>80-750</em></td> <td><em>85-335</em></td> <td><em>95-300</em></td> <td><em>17-45</em></td> <td><em>40-130</em></td> <td><em>80-725</em></td> <td><em>25-230</em></td> <td><em>10-35</em></td> </tr> <tr> <td class="indent1">Early pubertal girls</td> <td>150-750</td> <td>90-335</td> <td>95-300</td> <td>17-45</td> <td>35-130</td> <td>70-725</td> <td>55-230</td> <td>10-35</td> </tr> <tr> <td class="indent1">Adult females, follicular phase</td> <td>150-1070</td> <td>35-335</td> <td>95-300</td> <td>17-45</td> <td>75-255</td> <td>250-1470</td> <td>60-250</td> <td>20-60</td> </tr> <tr> <td class="subtitle2_left">Conversion multipliers to SI units</td> <td class="subtitle2_left">0.0316 (nmol/L)</td> <td class="subtitle2_left">0.0303 (nmol/L)</td> <td class="subtitle2_left">0.0289 (nmol/L)</td> <td class="subtitle2_left">0.0276 (micromol/L)</td> <td class="subtitle2_left">0.0271 (micromol/L)</td> <td class="subtitle2_left">0.0347 (nmol/L)</td> <td class="subtitle2_left">0.0349 (nmol/L)</td> <td class="subtitle2_left">0.0347 (nmol/L)</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>DHEA: dehydroepiandrosterone; DHEAS: dehydroepiandrosterone sulfate; IV: intravenously; SI units: International System of Units; LC-MSMS: liquid chromatography-tandem mass spectrometry.</p>
<p>* Values are from a standard specialty laboratory reference (2020) using radioimmunoassay after preparatory chromatography, except cortisol and DHEAS, which were measured by direct immunoassay. Values differ slightly among laboratories. These values generally agree with those by LC-MSMS methodology, except LC-MSMS yields DHEAS values approximately 55% lower<sup>[1]</sup>.</p>
<p>¶ Normal women who are heterozygous for 21-hydroxylase deficiency often have 17-hydroxyprogesterone responses to ACTH greater than those shown. This genotype is present in approximately 2% of women<sup>[2]</sup>.</p>
Δ 17-hydroxyprogesterone begins rising in the preovulatory phase and peaks as high as 400 ng/dL in the luteal phase of the cycle.</div><div class="graphic_reference">References:
<ol>
<li>Rosenfield RL. Normal and Premature Adrenarche. Endocr Rev 2021; 42:783.</li>
<li>Speiser PW, Arlt W, Auchus RJ, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018; 103:4043.</li>
</ol>
<p class="extra_spacing_top">Modified with permission from: Rosenfield R. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Endocrinol Metab 2007; 92:787. http://jcem.endojournals.org/. Copyright © 2007 The Endocrine Society.</p></div><div id="graphicVersion">Graphic 75217 Version 14.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
